Structure

Physi-Chem Properties

Molecular Weight:  378.2
Volume:  400.138
LogP:  3.631
LogD:  3.556
LogS:  -3.658
# Rotatable Bonds:  11
TPSA:  96.22
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  1
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.22
Synthetic Accessibility Score:  3.872
Fsp3:  0.476
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.684
MDCK Permeability:  1.526523192296736e-05
Pgp-inhibitor:  0.016
Pgp-substrate:  0.065
Human Intestinal Absorption (HIA):  0.052
20% Bioavailability (F20%):  0.83
30% Bioavailability (F30%):  0.013

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.028
Plasma Protein Binding (PPB):  98.32836151123047%
Volume Distribution (VD):  0.472
Pgp-substrate:  0.8849101066589355%

ADMET: Metabolism

CYP1A2-inhibitor:  0.885
CYP1A2-substrate:  0.761
CYP2C19-inhibitor:  0.27
CYP2C19-substrate:  0.133
CYP2C9-inhibitor:  0.59
CYP2C9-substrate:  0.926
CYP2D6-inhibitor:  0.934
CYP2D6-substrate:  0.864
CYP3A4-inhibitor:  0.63
CYP3A4-substrate:  0.248

ADMET: Excretion

Clearance (CL):  9.506
Half-life (T1/2):  0.48

ADMET: Toxicity

hERG Blockers:  0.035
Human Hepatotoxicity (H-HT):  0.451
Drug-inuced Liver Injury (DILI):  0.128
AMES Toxicity:  0.252
Rat Oral Acute Toxicity:  0.06
Maximum Recommended Daily Dose:  0.814
Skin Sensitization:  0.687
Carcinogencity:  0.258
Eye Corrosion:  0.003
Eye Irritation:  0.682
Respiratory Toxicity:  0.807

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470398

Natural Product ID:  NPC470398
Common Name*:   Olympicin D
IUPAC Name:   1-[2-[(2E)-6-hydroperoxy-3,7-dimethylocta-2,7-dienoxy]-4,6-dihydroxyphenyl]-2-methylbutan-1-one
Synonyms:   Olympicin D
Standard InCHIKey:  BMEORAQEILRDFC-NTEUORMPSA-N
Standard InCHI:  InChI=1S/C21H30O6/c1-6-15(5)21(24)20-17(23)11-16(22)12-19(20)26-10-9-14(4)7-8-18(27-25)13(2)3/h9,11-12,15,18,22-23,25H,2,6-8,10H2,1,3-5H3/b14-9+
SMILES:  CCC(C(=O)c1c(OC/C=C(/CCC(C(=C)C)OO)C)cc(cc1O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2023361
PubChem CID:   57379194
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0001831] Carbonyl compounds
          • [CHEMONTID:0000118] Ketones
            • [CHEMONTID:0003670] Aryl ketones
              • [CHEMONTID:0004296] Phenylketones
                • [CHEMONTID:0004298] Alkyl-phenylketones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22037 Hypericum olympicum Species Hypericaceae Eukaryota n.a. n.a. n.a. PMID[21899267]
NPO22037 Hypericum olympicum Species Hypericaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 64.0 ug.mL-1 PMID[514600]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470398 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9847 High Similarity NPC470397
0.9846 High Similarity NPC144027
0.9846 High Similarity NPC236974
0.9699 High Similarity NPC470399
0.9697 High Similarity NPC156910
0.9697 High Similarity NPC187826
0.9692 High Similarity NPC203817
0.9481 High Similarity NPC140890
0.9481 High Similarity NPC139554
0.9412 High Similarity NPC6407
0.9412 High Similarity NPC188243
0.9412 High Similarity NPC129853
0.9412 High Similarity NPC76445
0.9412 High Similarity NPC284550
0.9412 High Similarity NPC110228
0.9407 High Similarity NPC124269
0.9403 High Similarity NPC240147
0.9403 High Similarity NPC121243
0.9403 High Similarity NPC174999
0.9394 High Similarity NPC25937
0.9394 High Similarity NPC10971
0.9385 High Similarity NPC69235
0.9385 High Similarity NPC212379
0.9348 High Similarity NPC81697
0.9348 High Similarity NPC125894
0.9348 High Similarity NPC223812
0.9348 High Similarity NPC77794
0.9348 High Similarity NPC107177
0.9348 High Similarity NPC85162
0.9348 High Similarity NPC278249
0.9343 High Similarity NPC166689
0.9343 High Similarity NPC96408
0.9343 High Similarity NPC17170
0.9343 High Similarity NPC156190
0.9343 High Similarity NPC258630
0.9343 High Similarity NPC279650
0.9338 High Similarity NPC274784
0.9338 High Similarity NPC329203
0.9338 High Similarity NPC20709
0.9338 High Similarity NPC265871
0.9338 High Similarity NPC310135
0.9338 High Similarity NPC150648
0.9338 High Similarity NPC23257
0.9338 High Similarity NPC222342
0.9338 High Similarity NPC225153
0.9333 High Similarity NPC188879
0.9328 High Similarity NPC60667
0.9323 High Similarity NPC223457
0.9318 High Similarity NPC475589
0.9318 High Similarity NPC31872
0.9318 High Similarity NPC473584
0.9281 High Similarity NPC473013
0.9281 High Similarity NPC235217
0.9281 High Similarity NPC473014
0.9281 High Similarity NPC473015
0.9281 High Similarity NPC131579
0.9281 High Similarity NPC131568
0.9275 High Similarity NPC107572
0.9275 High Similarity NPC64915
0.9275 High Similarity NPC324134
0.9275 High Similarity NPC223500
0.9275 High Similarity NPC166934
0.9275 High Similarity NPC167624
0.9275 High Similarity NPC227579
0.9275 High Similarity NPC1089
0.9275 High Similarity NPC37496
0.9275 High Similarity NPC40833
0.9275 High Similarity NPC324436
0.9275 High Similarity NPC76338
0.9275 High Similarity NPC32739
0.9275 High Similarity NPC220998
0.9275 High Similarity NPC265040
0.9275 High Similarity NPC328164
0.9275 High Similarity NPC306829
0.9275 High Similarity NPC194432
0.9275 High Similarity NPC76372
0.9275 High Similarity NPC161506
0.9275 High Similarity NPC148757
0.9275 High Similarity NPC125855
0.9275 High Similarity NPC296917
0.9275 High Similarity NPC10937
0.9275 High Similarity NPC66515
0.9275 High Similarity NPC228504
0.9275 High Similarity NPC78
0.9275 High Similarity NPC182852
0.9275 High Similarity NPC166482
0.9275 High Similarity NPC177354
0.927 High Similarity NPC471587
0.927 High Similarity NPC307990
0.927 High Similarity NPC16455
0.9265 High Similarity NPC474487
0.9265 High Similarity NPC470672
0.9265 High Similarity NPC470669
0.9265 High Similarity NPC470668
0.9265 High Similarity NPC474504
0.9265 High Similarity NPC131130
0.9265 High Similarity NPC470671
0.9265 High Similarity NPC118813
0.9259 High Similarity NPC240593
0.9254 High Similarity NPC125920
0.9242 High Similarity NPC270369
0.9242 High Similarity NPC324482
0.9242 High Similarity NPC5515
0.9231 High Similarity NPC128428
0.9231 High Similarity NPC305518
0.9214 High Similarity NPC285630
0.9214 High Similarity NPC476088
0.9214 High Similarity NPC127059
0.9214 High Similarity NPC474161
0.9209 High Similarity NPC75049
0.9209 High Similarity NPC169591
0.9209 High Similarity NPC185276
0.9209 High Similarity NPC164980
0.9209 High Similarity NPC175504
0.9209 High Similarity NPC149026
0.9209 High Similarity NPC39329
0.9209 High Similarity NPC143896
0.9209 High Similarity NPC257097
0.9209 High Similarity NPC310130
0.9209 High Similarity NPC150408
0.9209 High Similarity NPC316816
0.9209 High Similarity NPC221432
0.9209 High Similarity NPC68104
0.9209 High Similarity NPC91560
0.9209 High Similarity NPC478086
0.9209 High Similarity NPC214166
0.9203 High Similarity NPC213322
0.9203 High Similarity NPC312391
0.9203 High Similarity NPC324386
0.9203 High Similarity NPC4743
0.9203 High Similarity NPC110038
0.9203 High Similarity NPC171870
0.9203 High Similarity NPC282300
0.9203 High Similarity NPC248372
0.9197 High Similarity NPC37206
0.9197 High Similarity NPC261234
0.9191 High Similarity NPC13768
0.9191 High Similarity NPC295261
0.9191 High Similarity NPC107586
0.9191 High Similarity NPC296490
0.9191 High Similarity NPC79943
0.9191 High Similarity NPC243083
0.9191 High Similarity NPC32441
0.9191 High Similarity NPC287246
0.9191 High Similarity NPC12296
0.9185 High Similarity NPC84699
0.9179 High Similarity NPC144051
0.9179 High Similarity NPC28753
0.9179 High Similarity NPC93756
0.9179 High Similarity NPC20560
0.9179 High Similarity NPC18877
0.9179 High Similarity NPC159623
0.9179 High Similarity NPC294593
0.9179 High Similarity NPC108113
0.9179 High Similarity NPC82225
0.9179 High Similarity NPC204960
0.9173 High Similarity NPC27490
0.9167 High Similarity NPC84772
0.9149 High Similarity NPC473133
0.9149 High Similarity NPC47388
0.9149 High Similarity NPC470670
0.9143 High Similarity NPC236766
0.9143 High Similarity NPC197252
0.9143 High Similarity NPC311144
0.9143 High Similarity NPC209040
0.9143 High Similarity NPC224714
0.9143 High Similarity NPC470890
0.9143 High Similarity NPC271288
0.9143 High Similarity NPC319752
0.9137 High Similarity NPC202981
0.9137 High Similarity NPC73028
0.9137 High Similarity NPC325346
0.913 High Similarity NPC241100
0.913 High Similarity NPC477272
0.913 High Similarity NPC159275
0.9124 High Similarity NPC280284
0.9124 High Similarity NPC147686
0.9124 High Similarity NPC329225
0.9124 High Similarity NPC99333
0.9124 High Similarity NPC472460
0.9124 High Similarity NPC188947
0.9118 High Similarity NPC47815
0.9118 High Similarity NPC13408
0.9118 High Similarity NPC29353
0.9118 High Similarity NPC231772
0.9118 High Similarity NPC124784
0.9118 High Similarity NPC473887
0.9118 High Similarity NPC127447
0.9118 High Similarity NPC194281
0.9118 High Similarity NPC234133
0.9111 High Similarity NPC164136
0.9111 High Similarity NPC286336
0.9091 High Similarity NPC473894
0.9091 High Similarity NPC230818
0.9078 High Similarity NPC470647
0.9078 High Similarity NPC24136
0.9078 High Similarity NPC246948
0.9078 High Similarity NPC470134
0.9078 High Similarity NPC142405
0.9078 High Similarity NPC176229

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470398 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9191 High Similarity NPD1552 Clinical (unspecified phase)
0.9191 High Similarity NPD1550 Clinical (unspecified phase)
0.9124 High Similarity NPD1549 Phase 2
0.8889 High Similarity NPD1240 Approved
0.8873 High Similarity NPD4378 Clinical (unspecified phase)
0.8841 High Similarity NPD2796 Approved
0.8768 High Similarity NPD1510 Phase 2
0.8759 High Similarity NPD1607 Approved
0.8716 High Similarity NPD8443 Clinical (unspecified phase)
0.8649 High Similarity NPD2393 Clinical (unspecified phase)
0.8611 High Similarity NPD7410 Clinical (unspecified phase)
0.8582 High Similarity NPD970 Clinical (unspecified phase)
0.8581 High Similarity NPD1934 Approved
0.8542 High Similarity NPD6799 Approved
0.8514 High Similarity NPD7411 Suspended
0.8489 Intermediate Similarity NPD6651 Approved
0.8477 Intermediate Similarity NPD7075 Discontinued
0.8446 Intermediate Similarity NPD4380 Phase 2
0.84 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8392 Intermediate Similarity NPD2800 Approved
0.8355 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD6801 Discontinued
0.8333 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8322 Intermediate Similarity NPD6599 Discontinued
0.8289 Intermediate Similarity NPD3882 Suspended
0.8288 Intermediate Similarity NPD1511 Approved
0.8278 Intermediate Similarity NPD7819 Suspended
0.8278 Intermediate Similarity NPD2801 Approved
0.8231 Intermediate Similarity NPD2532 Approved
0.8231 Intermediate Similarity NPD2533 Approved
0.8231 Intermediate Similarity NPD2534 Approved
0.8194 Intermediate Similarity NPD6959 Discontinued
0.8182 Intermediate Similarity NPD1551 Phase 2
0.8176 Intermediate Similarity NPD1512 Approved
0.8153 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8153 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8153 Intermediate Similarity NPD6166 Phase 2
0.8138 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8082 Intermediate Similarity NPD3750 Approved
0.8082 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8052 Intermediate Similarity NPD7768 Phase 2
0.8038 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8015 Intermediate Similarity NPD9717 Approved
0.8014 Intermediate Similarity NPD2654 Approved
0.8014 Intermediate Similarity NPD1243 Approved
0.8 Intermediate Similarity NPD5403 Approved
0.8 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD3817 Phase 2
0.795 Intermediate Similarity NPD7074 Phase 3
0.7937 Intermediate Similarity NPD3818 Discontinued
0.7935 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7931 Intermediate Similarity NPD6099 Approved
0.7931 Intermediate Similarity NPD6100 Approved
0.7898 Intermediate Similarity NPD5494 Approved
0.7888 Intermediate Similarity NPD7054 Approved
0.7885 Intermediate Similarity NPD3749 Approved
0.7881 Intermediate Similarity NPD920 Approved
0.7877 Intermediate Similarity NPD2344 Approved
0.7867 Intermediate Similarity NPD5401 Approved
0.7862 Intermediate Similarity NPD2799 Discontinued
0.7852 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7842 Intermediate Similarity NPD1203 Approved
0.784 Intermediate Similarity NPD7472 Approved
0.7838 Intermediate Similarity NPD4628 Phase 3
0.781 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.781 Intermediate Similarity NPD422 Phase 1
0.7808 Intermediate Similarity NPD2935 Discontinued
0.7805 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7801 Intermediate Similarity NPD6832 Phase 2
0.7801 Intermediate Similarity NPD4908 Phase 1
0.7791 Intermediate Similarity NPD5953 Discontinued
0.7791 Intermediate Similarity NPD6797 Phase 2
0.7778 Intermediate Similarity NPD7286 Phase 2
0.7778 Intermediate Similarity NPD9545 Approved
0.7748 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD7251 Discontinued
0.774 Intermediate Similarity NPD3748 Approved
0.774 Intermediate Similarity NPD7033 Discontinued
0.7718 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD7808 Phase 3
0.7692 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD3268 Approved
0.7681 Intermediate Similarity NPD1610 Phase 2
0.7667 Intermediate Similarity NPD2309 Approved
0.7655 Intermediate Similarity NPD230 Phase 1
0.7655 Intermediate Similarity NPD5124 Phase 1
0.7655 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD7473 Discontinued
0.7647 Intermediate Similarity NPD1548 Phase 1
0.7643 Intermediate Similarity NPD5402 Approved
0.7636 Intermediate Similarity NPD6559 Discontinued
0.763 Intermediate Similarity NPD9493 Approved
0.759 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7589 Intermediate Similarity NPD2797 Approved
0.7586 Intermediate Similarity NPD943 Approved
0.7578 Intermediate Similarity NPD6232 Discontinued
0.7537 Intermediate Similarity NPD1241 Discontinued
0.7535 Intermediate Similarity NPD1019 Discontinued
0.7535 Intermediate Similarity NPD2798 Approved
0.7515 Intermediate Similarity NPD1729 Discontinued
0.75 Intermediate Similarity NPD919 Approved
0.75 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7469 Intermediate Similarity NPD5711 Approved
0.7469 Intermediate Similarity NPD5710 Approved
0.7457 Intermediate Similarity NPD4360 Phase 2
0.7457 Intermediate Similarity NPD4363 Phase 3
0.7455 Intermediate Similarity NPD5844 Phase 1
0.7452 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7448 Intermediate Similarity NPD1296 Phase 2
0.7448 Intermediate Similarity NPD411 Approved
0.7448 Intermediate Similarity NPD2313 Discontinued
0.7447 Intermediate Similarity NPD4749 Approved
0.7425 Intermediate Similarity NPD6104 Discontinued
0.7423 Intermediate Similarity NPD3926 Phase 2
0.7415 Intermediate Similarity NPD447 Suspended
0.7407 Intermediate Similarity NPD1247 Approved
0.7403 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD2403 Approved
0.7376 Intermediate Similarity NPD3972 Approved
0.7376 Intermediate Similarity NPD1608 Approved
0.7343 Intermediate Similarity NPD3267 Approved
0.7343 Intermediate Similarity NPD3266 Approved
0.7338 Intermediate Similarity NPD7390 Discontinued
0.7329 Intermediate Similarity NPD6798 Discontinued
0.7329 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD3226 Approved
0.7314 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7314 Intermediate Similarity NPD4361 Phase 2
0.7297 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD6355 Discontinued
0.7285 Intermediate Similarity NPD6004 Phase 3
0.7285 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD6002 Phase 3
0.7285 Intermediate Similarity NPD6005 Phase 3
0.7273 Intermediate Similarity NPD3225 Approved
0.7273 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD4308 Phase 3
0.7267 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD1465 Phase 2
0.723 Intermediate Similarity NPD1613 Approved
0.723 Intermediate Similarity NPD3142 Approved
0.723 Intermediate Similarity NPD3140 Approved
0.723 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7214 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD1652 Phase 2
0.7181 Intermediate Similarity NPD1933 Approved
0.7179 Intermediate Similarity NPD4662 Approved
0.7179 Intermediate Similarity NPD4661 Approved
0.7172 Intermediate Similarity NPD5647 Approved
0.7171 Intermediate Similarity NPD2346 Discontinued
0.7163 Intermediate Similarity NPD1778 Approved
0.7163 Intermediate Similarity NPD17 Approved
0.7143 Intermediate Similarity NPD3027 Phase 3
0.7124 Intermediate Similarity NPD2424 Discontinued
0.7123 Intermediate Similarity NPD2861 Phase 2
0.7123 Intermediate Similarity NPD9494 Approved
0.7123 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD3658 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD7458 Discontinued
0.7099 Intermediate Similarity NPD846 Approved
0.7099 Intermediate Similarity NPD4288 Approved
0.7099 Intermediate Similarity NPD940 Approved
0.7099 Intermediate Similarity NPD2296 Approved
0.7097 Intermediate Similarity NPD3887 Approved
0.7091 Intermediate Similarity NPD7199 Phase 2
0.7075 Intermediate Similarity NPD1008 Clinical (unspecified phase)
0.7075 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7066 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7055 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD7229 Phase 3
0.7047 Intermediate Similarity NPD6233 Phase 2
0.7037 Intermediate Similarity NPD9266 Approved
0.7037 Intermediate Similarity NPD5760 Phase 2
0.7037 Intermediate Similarity NPD74 Approved
0.7037 Intermediate Similarity NPD2684 Approved
0.7037 Intermediate Similarity NPD5761 Phase 2
0.7034 Intermediate Similarity NPD1876 Approved
0.7027 Intermediate Similarity NPD4625 Phase 3
0.7021 Intermediate Similarity NPD1894 Discontinued
0.7014 Intermediate Similarity NPD1481 Phase 2
0.7006 Intermediate Similarity NPD7212 Phase 2
0.7006 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD7213 Phase 3
0.7 Intermediate Similarity NPD4307 Phase 2
0.6994 Remote Similarity NPD5353 Approved
0.6993 Remote Similarity NPD3496 Discontinued
0.6987 Remote Similarity NPD2354 Approved
0.6982 Remote Similarity NPD3751 Discontinued
0.6982 Remote Similarity NPD7893 Clinical (unspecified phase)
0.698 Remote Similarity NPD1699 Clinical (unspecified phase)
0.698 Remote Similarity NPD3764 Approved
0.6975 Remote Similarity NPD37 Approved
0.6975 Remote Similarity NPD7577 Discontinued
0.6975 Remote Similarity NPD6279 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data